Overview

Downstream Bioprocessing Controllers Market is estimated to value over USD 2 billion by 2027 end with a CAGR of over 17% during the forecast period 2020 to 2027.

Rising insistence for biopharmaceuticals, increased acceptance of single-use technology, expansion of the capacity by the companies manufacturing biopharmaceutical products are some of the key factors driving the market growth. Furthermore, rising penetration of large molecules and biologics shall increase the acceptance of downstream methods, thereby proliferating the market. Purity, reasonable unit cost and efficacy are some of the key parameters to be considered for producing drugs. Downstream technique is often used in both industrial as well as lab applications due to an escalated insistence for biologics, which shall augment the downstream bioprocessing controllers market growth.
High throughput in the development process, perfusion chromatography, usage of data analytics and affinity chromatography are some of the crucial developments in downstream processing. Furthermore, the advantages related to the single use technology like substantial reduction in the facility construction time and capital cost which shall accelerate the growth of the market. Other benefits like improves mobility, increased scalability, eliminating cross contamination risk, reduced demand for sterilization and cleaning and high productivity shall boost the demand for downstream method significantly. The key market players are initiating multiple research and development activities for cutting down the total production cost, thereby minimizing the cost of retail products. These activities have escalated the investments in biotech research, thereby shortening the time of processing and the scope of throughput.

Major key players involved in Downstream Bioprocessing Controllers Market:
• Merck Group
• Danaher Corporation
• GE Healthcare
• ARTeSYN Biosolutions Ireland Ltd
• Sepragen Corporation
• Parker-Hannifin Corporation
• 3M Company
• VERDOT Ips²
• Repligen Corporation
• Sartorius (Note: The list of the major players will be updated with the latest market scenario and trends)

Downstream Bioprocessing Controllers Market

Market Segmentation:

By Procedure
• Chromatography
• Tangential Flow Filtration

By Product
•   Chromatography Controller System
•   TFF Controller System
•   Disposable Floe Path

By Application
• Commercial Bioprocessing
o Monoclonal Antibody Production
o Therapeutic Protein Production
o Vaccine Production
o Cell and Gene Therapy
• Research Bioprocessing

By End User
•   Pharmaceutical and Biotechnology Companies
•   Academic and Research Institutes
•   Contract Research Organizations
•   Food and Beverage Companies

By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is classified into procedure, product, application, end user and region. The procedure segment is fragmented into chromatography and tangential flow filtration. The tangential flow filtration procedure is predicted to hold the largest downstream bioprocessing controllers market share owing to a rise in the acceptance of tangential flow filtration processes for removing biofilm, bioburden and reducing endotoxin from biopharmaceutical fluids and all this with no effect on the product quality. Product-wise, the market is divided into chromatography controller system, TFF controller system, disposable flow path. The TFF products like disposable flow path dominated the market and this can be credited to an increased acceptance of TFF processes implemented with single use technology in meeting the rising insistence for concentrated protein with reduced time and capital investment. The application segment is divided into commercial bioprocessing and research bioprocessing. The commercial bioprocessing segment is fragmented into monoclonal antibody production, therapeutic protein production, vaccine production and cell and gene therapy. The commercial bioprocessing is predicted to lead the market and this mainly due to increased insistence for biopharmaceutical products, rise in the number of approvals for antibody products. The end user segment is categorised into pharmaceutical and biotechnology companies, contract manufacturing organization and academic and research institutes. The pharmaceutical and biotechnology companies led the market, and this can be credited to a high rate of consumption of bioprocessing consumables and equipment by these companies.

Regional Analysis:

The North America region is anticipated to dominate the market owing to the advancements in downstream technology and a strong presence of key biopharmaceutical companies in the region. Furthermore, the government has heavily invested in the research and development activities pertaining to bioprocessing controllers which has boosted the market growth in the region. The Asia Pacific region is expected to grow at a substantial rate during the forecast period with key players expanding their businesses in the region. For instance, JHL Biotech of Taiwan uses modular SUT that is provided by GE Healthcare Life Sciences for constructing a biopharma facility in the province of Wuhan, China. There has been a rise in the number of approvals of biologics in developing and developed countries like China, Japan. For example, Chugai Pharmaceutical Co. Ltd. from Japan and the National Cancer Center, Japan has signed a research agreement for the project Master Key which shall promote R&D in genomic medicines and cancer medicines.

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global downstream bioprocessing controllers market by procedure, by product, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com